Evidence map›Paper›PMID 36227617›Full record

ArticleMedical physics2022

Three-dimensional dose and LET

Fakhriddin Pirlepesov, Lydia Wilson, Vadim P Moskvin, Alex Breuer, Franz Parkins, John T Lucas, Thomas E Merchant, Austin M Faught

Open access · greenAbstract read
In one paragraph

Article in Medical physics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Fakhriddin PirlepesovDepartment of Radiation Oncology, St. Jude Children's Research Hospital.
Lydia WilsonDepartment of Radiation Oncology, St. Jude Children's Research Hospital.
Vadim P MoskvinDepartment of Radiation Oncology, St. Jude Children's Research Hospital.
Alex BreuerDepartment of Pathology, St. Jude Children's Research Hospital.
Franz ParkinsDepartment of Information Services, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
John T LucasDepartment of Radiation Oncology, St. Jude Children's Research Hospital.
Thomas E MerchantDepartment of Radiation Oncology, St. Jude Children's Research Hospital.
Austin M FaughtDepartment of Radiation Oncology, St. Jude Children's Research Hospital.
St. Jude Children's Research Hospital · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
American Lebanese Syrian Associated CharitiesNCI NIH HHS P30 CA021765
6 · The paper itself

Abstract

purposeChallenges in proton therapy include identifying patients most likely to benefit; ensuring consistent, high-quality plans as its adoption becomes more widespread; and recognizing biological uncertainties that may be related to increased relative biologic effectiveness driven by linear energy transfer (LET). Knowledge-based planning (KBP) is a domain that may help to address all three.

methodsArtificial neural networks were trained using 117 unique treatment plans and associated dose and dose-weighted LET (LET

resultsDose-volume metrics significantly differed (α = 0.05) between predicted and planned dose distributions in only one dose-volume metric, D

conclusionsWe have devised the first three-dimensional dose and LET

Indexed as

Proton TherapyHumansLinear Energy TransferNeural Networks, ComputerRadiotherapy DosageRadiotherapy Planning, Computer-AssistedRelative Biological Effectivenessartificial intelligenceknowledge-based planningneural networksproton therapy

Identifiers

PMID36227617
PMCPMC9872814
OpenAlexW4304987525

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.